chloroquine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, E | 1 |
| Imafuku, S | 1 |
| Ishii, K | 1 |
| Itoh, R | 1 |
| Chou, B | 1 |
| Soejima, T | 1 |
| Nakayama, J | 1 |
| Hiromatsu, K | 1 |
1 other study available for chloroquine and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in human monocytic cells.
Topics: Adenine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Autophagy; Autophagy-Relat | 2013 |